Peter Schmid

13.3k citations
192 papers · 9.5k · 5 hit papers · h-index 43

Impact in

  • Oncology top 0.5%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Cancer Immunotherapy and Biomarkers
    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics

Papers in

Peter Schmid

173 papers receiving 9.2k citations

Peter Schmid's Hit Papers

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer 2022 · 1.9k citations
1.9k0+2+4Years since publication50010001.5k

Peers

Peter Schmid
Comparison fields: 5 of 158
  • Oncology 4.1k
  • Cancer Research 1.4k
  • Pulmonary and Respiratory Medicine 1.9k
  • Radiology, Nuclear Medicine and Imaging 915
  • Biological Psychiatry 93
Replace Charles L. Shapiro with:
Charles L. Shapiro United States
Patrick J. Flynn United States
Tomohiro Matsuda Japan
William Blair Farrar United States
William J.M. Hrushesky United States
Maryam Lustberg United States
Xiaoping Gu China
Nicholas A. Pavlidis Greece
Loretta Marie Itri United States
N. Lynn Henry United States
Peter Schmid relative to Charles L. Shapiro United States Charles L. Shapiro's profile →
Citations per field
00.5×2×2.8×
Charles L. Shapiro · 1×
Citations per year

Countries citing papers authored by Peter Schmid

Since Specialization
Citations

This map shows the geographic impact of Peter Schmid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Schmid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Schmid more than expected).

Fields of papers citing papers by Peter Schmid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Schmid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Schmid. The network helps show where Peter Schmid may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Schmid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Schmid Line = papers co-authored together Peter Schmid links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 192 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
Hit paper breakdown →
20221875
2
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
Hit paper breakdown →
20211197
3
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
Hit paper breakdown →
2021993
4
Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study
Hit paper breakdown →
2020324
5 1995286
6
Sacituzumab Govitecan in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
Hit paper breakdown →
2022239
7 2009191
8 2009188
9 2020161
10
Melanoma-associated antigens as messenger RNA detection markers for melanoma.
1997146
11 2006119
12 2006113
13 1997100
14 201999
15 200395
16 200891
17 200790
18 199688
19 200678
20 201073

About Peter Schmid

Peter Schmid is a scholar working on Oncology, Cardiology and Cardiovascular Medicine, Complementary and alternative medicine, Cancer Research and Pulmonary and Respiratory Medicine, having authored 192 papers that have together received 9.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (20 papers), HER2/EGFR in Cancer Research (16 papers), Cardiovascular and exercise physiology (15 papers), Breast Cancer Treatment Studies (14 papers), Heart Rate Variability and Autonomic Control (14 papers), Advanced Breast Cancer Therapies (13 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Gestational Trophoblastic Disease Studies (9 papers). The work is most often cited by research in Oncology (4.1k citations), Cancer Research (1.4k citations), Pulmonary and Respiratory Medicine (1.9k citations), Radiology, Nuclear Medicine and Imaging (915 citations) and Biological Psychiatry (93 citations). Peter Schmid has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Philip M. Savage, Andrew J. Conrad, Tilman Steinert, Kurt Possinger, Dave S.�B. Hoon, Javier Cortés, Bernd Christian Flath, SERGE PETELIN von DUVILLARD, D L Morton and Rochus Pokan. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Medicine & Science in Sports & Exercise, Clinical Cancer Research and Breast Cancer Research and Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact